Intellipharmaceutics Stock Price (NASDAQ:IPCI)

Add to My Stocks
$2.75 $0.24 (9.56%) IPCI stock closing price Sep 19, 2018 (Closing)
Prev Close* : $2.51
Market Cap:
$10.93M
Day Low: $2.45
52 Week Low: $2.30
Open: $2.57
Volume: -
Day High: $3.09
52 Week High: $12.50
Dividend:
0.00

Latest Stock Market News

Latest Articles

Intellipharmaceutics News - From Partners

Intellipharmaceutics Announces Receipt of Nasdaq Notice   by Globe Newswire on Sep 20, 2017

IPCI Stockcharts

View IPCI PE ratio, PS ratio stocks charts and compare with peers.
IPCI Chart
Note: Compare Intellipharmaceutics stock price history with the index and industry peers.

Intellipharmaceutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
3.6
PB ratio (
price to book ratio
)
-17.11

Intellipharmaceutics Returns

ROE
(return on equity)
-

Intellipharmaceutics Financial Ratios

Asset Turnover
0.39
Receivables Turnover
5.21
Debt to Equity
-
Dividend Yield
0%

IPCI Industry Peers

Company Price Change (%)
Delmar Pharma (DMPI)0.740.04 (5.71%)
Uluru (ULUR)0.060 (0%)
Kempharma (KMPH)4.950.03 (0.6%)
Alexza (ALXA)0.940.02 (2.17%)
Amneal Pharmact (AMRX)23.80.34 (1.45%)
Supernus Pharma (SUPN)47.91 (2.13%)
Minerva Neurosciences (NERV)11.10 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

IntelliPharmaCeutics Intl Inc (USA) Stock News - Partner Headlines

Intellipharmaceutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues5.5M2.24M4.09M8.76M1.52M
Net Income-8.85M-10.14M-7.43M-3.85M-11.49M
Total Operating Expense12.55M11.7M10.82M11.92M7.94M
View Intellipharmaceutics income statement
balance sheet20172016201520142013
Total Assets7.39M7.97M5.22M7.87M4.37M
Total Liabilities7.01M6.85M5.36M2.96M10.33M
Shareholders Equity-1.11M-0.13M4.9M-5.95M
View Intellipharmaceutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.03M1.1M2.76M-0.13M-1.47M
Net Cash from (used by) Operating Activities-6.1M-6.25M-3.78M-1.71M-6.92M
Increase (Decrease) in Prop Plant And Equipment-1.82M-0.51M-0.43M-0.76M-0.12M
View Intellipharmaceutics cash flow statement

Intellipharmaceutics Stock Message Board

An investor needs to spend $2.75 to buy IPCI stock, as the closing Intellipharmaceutics stock price is $2.75. Stock price or share price can be used to find the total market value of a company. Intellipharmaceutics market cap stands at $10.93M as of Sep 19, 2018. Intellipharmaceutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Intellipharmaceutics stock price and Intellipharmaceutics share price mean the same thing. 151,800 shares were traded with a closing stock price of $2.75 as of Sep 19, 2018, as can be seen from Intellipharmaceutics stock quote. One can view Intellipharmaceutics stock chart to follow the stock price trend. Intellipharmaceutics paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of IPCI, view Intellipharmaceutics stock price history.